Dallas, TX -- (SBWire) -- 11/22/2010 -- SandlerResearch announce it will carry Paget’s disease of Bone - Pipeline Assessment and Market Forecasts to 2017 Market Research Report in its Store.

GlobalData, the industry analysis specialist, has released its new report, “Paget’s disease of Bone – Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Paget’s disease of Bone market. The report identifies the key trends shaping and driving the global Paget’s disease of Bone market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Paget’s disease of Bone sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

GlobalData’s analysis reveals that the Paget’s disease of bone market was worth $678m in 2009. It is forecast to exhibit a negative compound annual growth rate (CAGR) of 5% for the next eight years and is expected to reach $463m by 2017. The negative growth rate is primarily attributable to the patent expiry of major approved drugs and a weak pipeline for the indication. Furthermore, a substantial decrease in the prevalence of Paget’s disease of bone will lead to a drop in the global prescription population. The market will witness generic erosion owing to the patent expiry of products such as Actonel Reclast and Miacalcin. The market has been steadily declining over the past few years and this trend is likely to continue

Scope
The report provides information on the key drivers and challenges of the Paget’s disease of Bone market. Its scope includes:
- Annualized global Paget’s disease of Bone market revenues data from 2001 to 2009, forecast for eight years to 2017.

- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as Antagonist of Wnt Signaling and osteoclast activity inhibitor.

- Analysis of the current and future competition in the global Paget’s disease of Bone market. Key market player covered is Genta Incorporated.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Paget’s disease of Bone therapeutics market

Reasons to buy
The report will enhance your decision making capability. It will allow you to:

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global Paget’s disease of Bone market.

- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Paget’s disease of Bone market in future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- What’s the next big thing in the global Paget’s disease of Bone market landscape? – Identify, understand and capitalize.

Browse complete Report on: Paget’s disease of Bone - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/41249-pagets-disease-of-bone-pipeline-assessment-and-market-forecast.html

1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Paget’s Disease of Bone: Market Characterization 4
2.1 Overview 4
2.2 GlobalData Pipeline Report Guidance 4
3 Paget’s Disease of Bone Therapeutics Market: Market Characterization 5
3.1 Paget’s Disease of Bone Therapeutics Market Size 5
3.2 Paget’s Disease of Bone Therapeutics Market Forecast and CAGR 6
3.3 Drivers and Barriers for the Paget’s Disease of Bone Therapeutics Market 7
3.3.1 Drivers for the Paget’s Disease of Bone Therapeutics Market 7
3.3.2 Barriers of the Paget’s Disease of Bone Therapeutics Market 7
3.4 Opportunity and Unmet Need 8
3.5 Key Takeaway 9
4 Paget’s Disease of Bone Therapeutics Market: Competitive Assessment 10
4.1 Overview 10
4.2 Strategic Competitor Assessment 10
4.3 Product Profile for the Major Marketed Products in the Paget’s Disease of Bone Therapeutics Market 11
4.3.1 Risedronate sodium (Actonel) 11
4.3.2 Alendronate sodium (Fosamax) 12
4.3.3 Zoledronic Acid (Reclast/Aclast) 13
4.3.4 Pamidronate Disodium (Aredia) 14
4.3.5 Tiludronate disodium (Skelid) 14
4.3.6 Salmon calcitonin (Miacalcin) 15
4.4 Key Takeaway 17
5 Paget’s disease of bone: Pipeline Assessment 18
5.1 Overview 18
5.2 Strategic Pipeline Assessment 18
5.2.1 Technology Trends Analytic Framework 18
5.3 Paget’s disease of bone Therapeutics – Promising Drugs under Clinical Development 20
5.3.1 Oral Gallium 20
5.4 Paget’s Disease of Bone Therapeutics Market – Clinical Pipeline by Mechanism of Action 21
5.5 Paget’s Disease of Bone Pipeline – Pipeline by Clinical Phases of Development 22
5.5.1 Paget’s Disease of Bone Therapeutics – Phase II Clinical Pipeline 22
5.5.2 Paget’s Disease of Bone Therapeutics – Preclinical Pipeline 22
5.6 Discontinued / Suspended Drugs for Paget’s Disease of Bone 22
5.7 Key Takeaway 22
6 Paget’s Disease of Bone Therapeutics Market: Implications for Future Market Competition 23
7 Paget’s Disease of Bone Therapeutics Market: Future Players in the Paget’s Disease of Bone Therapeutics Market 24
7.1 Introduction 24
7.2 Genta Incorporated 24
8 Paget’s Disease of Bone Therapeutics Market: Appendix 26
8.1 Market Definitions 26
8.2 KOL Interviews 26
8.3 Acronyms 26
8.4 Research Methodology 27
8.4.1 Coverage 27
8.4.2 Secondary Research 27
8.4.3 Forecasting 27
8.4.4 Primary Research 30
8.4.5 Expert Panel Validation 30
8.5 Contact Us 30
8.6 Disclaimer 31
8.7 Sources 31
Browse all Healthcare Market Research Reports on:
http://www.sandlerresearch.org/market-research/healthcare/
Browse all GlobalData Market Research Reports on:
http://www.sandlerresearch.org/publishers/globaldata/
Browse all Newly Published Market Research Reports on:
http://www.sandlerresearch.org/LatestReport.aspx

Related Reports:
Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/37204-peripheral-arterial-disease-pad-pipeline-assessment-and-marke.html

Alzheimer’s Disease - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/39674-alzheimers-disease-pipeline-assessment-and-market-forecasts-to.html

Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) - Pipeline Assessment and Market Forecasts to 2017
Huntington’s Disease - Pipeline Assessment and Market Forecasts to 2017http://www.sandlerresearch.org/reports/41251-huntingtons-disease-pipeline-assessment-and-market-forecasts-t.html

Paget’s Disease - Drug Pipeline Analysis and Market Forecasts to 2016
http://www.sandlerresearch.org/reports/16221-pagets-disease-drug-pipeline-analysis-and-market-forecasts-to-.html

About Sandler Research
Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.

Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.

We also provide 24/7 online and offline support to our customers.

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.sandlerresearch.com